Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Lucid Group’s cinematic performance at its company team briefing

May 13, 2019 | Bluedog, Digital, Lucid, Medical Communications, medcomms, medical education 

- PMLiVE

The Electric Cinema on Portobello Road, London, played host to Lucid’s first new-look quarterly team briefing, during which all UK employees gathered. Dennis O’Brien (CEO) kicked off with a performance update, reflecting on the transformative year so far, from the acquisition of Bluedog to new team structures, new clients and improved tools for learning and development.

Nigel Horn, Managing Director of Bluedog, was next up to provide an overview of Bluedog and its successful integration into Lucid. Nigel laid out their aspirations for 2019 – they have big plans to expand, creating a number of openings for new talented creatives and technical experts to join the business.

The second half of the meeting focused on the industry-leading tools the Learning and Development Department have recently launched to aid the learner-led, agile working environment Lucid has created. From LinkedIn Learning to a number of development tool kits and coaching programmes, the new resources will enable individuals and teams to bolster their technical and personal skills so they can create even more magic for their clients

At the end of the briefing, everyone had the opportunity to network, relax, reflect and get excited about the next meeting – the Electric Cinema will certainly be a hard act to follow.

This content was provided by Lucid Group Communications Limited

Company Details

- PMLiVE

Lucid Group Communications Limited

Email
Website

 Latest Content from  Lucid Group Communications Limited 

Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth

Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board

Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation

Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights…

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid…

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced…

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the…

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines…

Meet The Lucid Group Talent Team

Meet our talent team, they’re here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your…

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…

Extraordinary lives: advancing change in rare diseases (Part 1)